SEARCH

SEARCH BY CITATION

References

  • 1
    Zhang R, Kumar P, Ramcharan T, Reisin E., Kidney transplantation: the evolving challenges. Am J Med Sci. 2004; 328 3 156161.
  • 2
    Schnuelle P, Lorenz D, Trede M, Van Der Woude FJ., Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol. 1998; 9 11 21352141.
  • 3
    Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K., Comparison of survival probabilities for dialysis patients versus cadaveric renal transplant recipients. JAMA. 1993; 270 11 13391343.
  • 4
    Ojo AO, Port FK, Wolfe RA, Mauger EA, Williams L, Berling DP., Comparative mortality risks of chronic dialysis and cadaveric transplantation in black end-stage renal disease patients. Am J Kidney Dis. 1994; 24 1 5964.
  • 5
    Abecassis M, Bartlett ST, Collins AJ, et al. Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol. 2008; 3 2 471480.
  • 6
    Gaston RS, Danovitch GM, Adams PL, et al. The report of a national conference on the wait list for kidney transplantation. Am J Transplant. 2003; 3 7 775785.
  • 7
    Takemoto S, Terasaki PI, Gjertson DW, Cho YW, Cecka JM., Survival of nationally shared HLA-matched kidney transplants from cadaveric donors. N Engl J Med. 1992; 327 12 834839.
  • 8
    Takemoto SK, Terasaki PI, Gjertson DW, Cecka JM., Twelve years experience with national sharing of HLA-matched cadaveric kidneys for transplantation. N Engl J Med. 2000; 343 15 10781084.
  • 9
    Stegall MD, Dean PG, McBride MA, Wynn JJ., Survival of mandatorily shared cadaveric kidneys and their paybacks in the zero mismatch era. Transplantation. 2002; 74 5 670675.
  • 10
    Norman DJ., The kidney transplant wait-list: allocation of patients to a limited supply of organs. Semin Dial. 2005; 18 6 456459.
  • 11
    U.S. Organ Procurement and Transplantation Network the Scientific, Registry of Transplant Recipients. 2008 OPTN/SRTR Annual Report: Transplant Data 1998-2007 . www.ustransplant.org/annual_reports/curretn/data_tables_section5.html Accessed October 15, 2009.
  • 12
    Su X, Zenios SA, Chakkera H, Milford EL, Chertow GM., Diminishing significance of HLA matching in kidney transplantation. Am J Transplant. 2004; 4 9 150158.
  • 13
    OPTN/UNOS Transplantation Committee. Report to Board of Directors, June 2008. Available at: http://unos.org/NewsDetail Accessed October 15, 2009.
  • 14
    Opelz G, Dohler B., Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Transplantation. 2007; 84 2 137143.
  • 15
    Lee CM, Carter JT, Alfrey EJ, Ascher NL, Roberts JP, Freise CE., Prolonged cold ischemia time obviates the benefits of 0 HLA mismatches in renal transplantation. Arch Surg. 2000; 135 9 10161019.
  • 16
    Ceckaa JM, Reed EF., Histocompatibility testing, crossmatch, and allocation of kidney transplants In: DanovitchG. Handbook of Kidney Transplantation 4th ed. New York Lippincott, Williams & Wilkins 2005 4371.
  • 17
    Terasaki PI, Cecka JM, Gjertson DW, Takemoto S., High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med. 1995; 333 6 333336.
  • 18
    Gjertson DW, Cecka JM., Living unrelated donor kidney transplantation. Kidney Int. 2000; 58 2 491499.
  • 19
    Foss A, Leivestad T, Brekke IB, et al. Unrelated living donors in 141 kidney transplantations: a one-center study. Transplantation. 1998; 66 1 4952.
  • 20
    Humar A, Durand B, Gillingham K, Payne WD, Sutherland DE, Matas AJ., Living unrelated donors in kidney transplants: better long-term results than with non-HLA-identical living related donors? Transplantation. 2000; 69 9 19421945 .
  • 21
    Terasaki PI, Koyama H, Cecka JM, Gjertson DW., The hyperfiltration hypothesis in human renal transplantation. Transplantation. 1994; 57: 14501454.
  • 22
    Fuller TF, Feng S, Brennan TV, Tomlanovich S, Bostrom A, Freise CE., Increased rejection in living unrelated versus living related kidney transplants does not affect short-term function and survival. Transplantation. 2004; 78 7 10301035.
  • 23
    Prommool S, Jhangri GS, Cockfield SM, Halloran PF., Time dependency of factors affecting renal allograft survival. J Am Soc Nephrol. 2000; 11 3 565573.
  • 24
    Hardinger KL, Brennan DC, Schnitzler MA., Rabbit antithymocyte globulin is more beneficial in standard kidney than in extended donor recipients. Transplantation. 2009; 87 9 13721376.
  • 25
    Willoughby LM, Schnitzler MA, Brennan DC, et al. Early outcomes of thymoglobulin and basiliximab induction in kidney transplantation: application of statistical approaches to reduce bias in observational comparisons. Transplantation. 2009; 87 10 15201529.
  • 26
    Taber DJ, Weimert NA, Henderson F, et al. Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantation. Transplantation Proc. 2008; 40 10 34013407.